Because their interaction facilitates internalization and degradation of EGFR, the status of Ack1-mediated signaling could have implications for EGFR-driven cancers such as glioblastoma, nonsmall-cell lung cancer, and colorectal cancer. Here, TNK2 is linked to lung cancer.